MAPT and Alzheimer disease: While modern imaging techniques like MRI or PET evolve to be the new hope for the diagnosis of AD, biomedical science focuses on the design of new molecular probes for the specific labelling of biomarkers like Aβ and tau in vivo[6], [7], [8].